Tylenol Maker Kenvue Met With RFK Jr. In A Bid To Keep OTC Painkiller Off Autism List: Report
Synopsis
According to a Bloomberg report, Kenvue confirmed the meeting with RFK Jr., maintaining that acetaminophen, the active ingredient in Tylenol, does not cause autism.
Tylenol maker Kenvue Inc. (KVUE) reportedly met with the U.S. Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller off a list of treatments causing autism.
According to a Bloomberg report, Kenvue confirmed the meeting with RFK Jr., maintaining that acetaminophen, the active ingredient in Tylenol, does not cause autism.
Get updates to this story developing <directly on Stocktwits<.<
For updates and corrections, email newsroom[at]stocktwits[dot]com.<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.